name: Infectious agent detection by nucleic acid (DNA), Chlamydia trachomatis and Neisseria gonorrhoeae, multiplex amplified probe technique, urine, vaginal, pharyngeal, or rectal, each pathogen reported as detected or not detected


name: Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by multiplex amplified DNA probe technique


name: Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in pharyngeal specimen by multiplex amplified DNA probe technique


name: Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in rectal specimen by multiplex amplified DNA probe technique


name: Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimen by multiplex amplified DNA probe technique


name: Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in vaginal specimen by multiplex amplified DNA probe technique


name: Human papilloma virus (HPV), high-risk types (ie, 16, 18, 31, 33, 45, 52 and 58) qualitative mRNA expression of E6/E7 by quantitative polymerase chain reaction (qPCR)


name: Human papilloma virus (HPV) by quantitative polymerase chain reaction (qPCR)


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted, third dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose


name: Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (COVID-19) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; booster dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; first dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; second dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; third dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; booster dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, booster dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; booster dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, booster dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose


name: Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (COVID-19) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, third dose (6 months through 4 years)


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, booster dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, booster dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage; first dose, when administered to individuals 6 through 11 years


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage; second dose, when administered to individuals 6 through 11 years


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage; third dose, when administered to individuals 6 through 11 years


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage; booster dose, when administered to individuals 18 years and over


name: Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (COVID-19) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, booster dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, booster dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x1010 viral particles/0.5 mL dosage


name: Intramuscular administration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, , DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x1010 viral particles/0.5 mL dosage


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x1010 viral particles/0.5 mL dosage; booster dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, booster dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; first dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; second dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; third dose


name: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use


name: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use


name: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use


name: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use


name: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use


name: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use


name: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, for intramuscular use


name: Dengue vaccine, quadrivalent, live, 2 dose schedule, for subcutaneous use


name: Respiratory syncytial virus vaccine, preF, subunit, bivalent, for intramuscular use


name: Smallpox and monkeypox vaccine, attenuated vaccinia virus, live, non-replicating, preservative free, 0.5 mL dosage, suspension, for subcutaneous use


name: Vaccinia (smallpox) virus vaccine, live, lyophilized, 0.3 mL dosage, for percutaneous use


name: Hepatitis B (HepB) vaccine, CpG-adjuvanted, adult dosage, 2 dose schedule, for intramuscular use


name: Hepatitis B (HepB) vaccine, CpG-adjuvanted, adult dosage, 4 dose schedule, for intramuscular use


name: Eye training exercise performed by health care professional


name: Orthoptic training by qualified health care professional


name: Bilateral imaging of retina for detection of disease with point-of-care autonomous analysis and report


name: Bilateral imaging of retina for monitoring of disease with point-of-care autonomous analysis and report


name: Unilateral imaging of retina for detection of disease with point-of-care autonomous analysis and report


name: Unilateral imaging of retina for monitoring of disease with point-of-care autonomous analysis and report


name: Evaluation of eye adaptation to light and dark with interpretation and report


name: Injection for nonselective imaging of pulmonary artery during heart catheterization


name: Injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for selective pulmonary arterial angiography, unilateral (List separately in addition to code for primary procedure)


name: Injection for selective imaging of pulmonary artery during heart catheterization, on one side of body


name: Injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for selective pulmonary arterial angiography, bilateral (List separately in addition to code for primary procedure)


name: Injection for selective imaging of pulmonary artery during heart catheterization, on both sides of body


name: Bilateral injection procedure for selective pulmonary venous angiography of each distinct pulmonary vein with imaging supervision, interpretation, and report, during cardiac catheterization


name: Injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for selective pulmonary venous angiography of each distinct pulmonary vein during cardiac catheterization (List separately in addition to code for primary procedure)


name: Injection for selective imaging of pulmonary vein during heart catheterization


name: Injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for selective pulmonary angiography of major aortopulmonary collateral arteries (MAPCAs) arising off the aorta or its systemic branches, during cardiac catheterization for congenital heart defects, each distinct vessel (List separately in addition to code for primary procedure)


name: Injection for selective imaging of major aortopulmonary collateral arteries during heart catheterization


name: Injection procedure for selective pulmonary angiography of major aortopulmonary collateral arteries (MAPCAs) arising off systemic branches of aorta imaging supervision, interpretation, and report, during cardiac catheterization for congenital heart defects, each distinct vessel


name: Injection procedure for selective pulmonary angiography of major aortopulmonary collateral arteries (MAPCAs) arising off the aorta with imaging supervision, interpretation, and report, during cardiac catheterization for congenital heart defects, each distinct vessel


name: Quantitative pupillometry with physician or other qualified health care professional interpretation and report, unilateral or bilateral


name: Measurement of pupil with healthcare professional interpretation and report


name: Bilateral quantitative pupillometry with interpretation and report by a qualified health professional


name: Bilateral quantitative pupillometry with interpretation and report by physician


name: Unilateral quantitative pupillometry with interpretation and report by a qualified health professional


name: Unilateral quantitative pupillometry with interpretation and report by physician


name: Multiple-family group behavior management/modification training for parent(s)/guardian(s)/caregiver(s) of patients with a mental or physical health diagnosis, administered by physician or other qualified health care professional (without the patient present), face-to-face with multiple sets of parent(s)/guardian(s)/caregiver(s)


name: Multiple-family group behavior management/modification training for parent(s)/guardian(s)/caregiver(s) of patients with a mental or physical health diagnosis, administered by physician or other qualified health care professional (without the patient present), face-to-face with multiple sets of parent(s)/guardian(s)/caregiver(s); initial 60 minutes


name: Multiple-family group behavior management/modification training, face-to-face, initial 60 minutes


name: Face-to face multiple-family group behavior management/modification training for parents/guardians/caregivers of patients with mental health diagnosis, administered by a qualified health care professional, initial 60 minutes


name: Face-to face multiple-family group behavior management/modification training for parents/guardians/caregivers of patients with mental health diagnosis, administered by physician, initial 60 minutes


name: Face-to face multiple-family group behavior management/modification training for parents/guardians/caregivers of patients with physical health diagnosis, administered by a qualified health care professional, initial 60 minutes


name: Face-to face multiple-family group behavior management/modification training for parents/guardians/caregivers of patients with physical health diagnosis, administered by physician or other qualified health care professional, initial 60 minutes


name: Multiple-family group behavior management/modification training for parent(s)/guardian(s)/caregiver(s) of patients with a mental or physical health diagnosis, administered by physician or other qualified health care professional (without the patient present), face-to-face with multiple sets of parent(s)/guardian(s)/caregiver(s); each additional 15 minutes (List separately in addition to code for primary service)


name: Multiple-family group behavior management/modification training, face-to-face, each additional 15 minutes


name: Face-to face multiple-family group behavior management/modification training for parents/guardians/caregivers of patients with mental health diagnosis, administered by a qualified health care professional, each additional 15 minutes


name: Face-to face multiple-family group behavior management/modification training for parents/guardians/caregivers of patients with mental health diagnosis, administered by physician, each additional 15 minutes


name: Face-to face multiple-family group behavior management/modification training for parents/guardians/caregivers of patients with physical health diagnosis, administered by a qualified health care professional, each additional 15 minutes


name: Face-to face multiple-family group behavior management/modification training for parents/guardians/caregivers of patients with physical health diagnosis, administered by physician or other qualified health care professional, each additional 15 minutes


name: Remote therapeutic monitoring (eg, therapy adherence, therapy response)


name: Device supply with daily recording and programmed alert transmission for remote therapeutic monitoring of respiratory system, each 30 days


name: Device supply with daily recording and programmed alert transmission for remote therapy adherence monitoring of respiratory system, each 30 days


name: Device supply with daily recording for remote therapeutic monitoring of respiratory system, each 30 days


name: Device supply with daily recording for remote therapy adherence monitoring of respiratory system, each 30 days


name: Device supply with programmed alert transmission for remote therapeutic monitoring of respiratory system, each 30 days


name: Device supply with programmed alert transmission for remote therapy adherence monitoring of respiratory system, each 30 days


name: Device supply with programmed alert transmission for remote therapy response monitoring of respiratory system, each 30 days


name: Device supply with scheduled recording and programmed alert transmission for remote therapy response monitoring of respiratory system, each 30 days


name: Device supply with scheduled recording for remote therapeutic monitoring of respiratory system, each 30 days


name: Device supply with scheduled recording for remote therapy adherence monitoring of respiratory system, each 30 days


name: Device supply with scheduled recording and transmission for remote monitoring of musculoskeletal system, per 30 days


name: Device supply with programmed alert transmission for remote therapeutic monitoring of musculoskeletal system, each 30 days


name: Device supply with programmed alert transmission for remote therapy adherence monitoring of musculoskeletal system, each 30 days


name: Device supply with scheduled recording and programmed alert transmission for remote therapeutic monitoring of musculoskeletal system, each 30 days


name: Device supply with scheduled recording and programmed alert transmission for remote therapy adherence monitoring of musculoskeletal system, each 30 days


name: Device supply with scheduled recording and programmed alert transmission for remote therapy response monitoring of rmusculoskeletal system, each 30 days


name: Device supply with scheduled recording for remote therapeutic monitoring of musculoskeletal system, each 30 days


name: Device supply with scheduled recording for remote therapy adherence monitoring of musculoskeletal system, each 30 days


name: Remote therapeutic monitoring (eg, therapy adherence, therapy response); device(s) supply with scheduled (eg, daily) recording(s) and/or programmed alert(s) transmission to monitor cognitive behavioral therapy, each 30 days


name: Device supply with scheduled recording and transmission for remote monitoring of cognitive behavioral therapy, per 30 days


name: Device supply with daily recording and programmed alert transmission for remote therapeutic monitoring of cognitive behavior therapy, each 30 days


name: Device supply with daily recording and programmed alert transmission for remote therapy adherence monitoring of cognitive behavior therapy, each 30 days


name: Device supply with daily recording for remote therapeutic monitoring of cognitive behavior therapy, each 30 days


name: Device supply with daily recording for remote therapy adherence monitoring of cognitive behavior therapy, each 30 days


name: Device supply with programmed alert transmission for remote therapeutic monitoring of cognitive behavior therapy, each 30 days


name: Device supply with programmed alert transmission for remote therapy adherence monitoring of cognitive behavior therapy, each 30 days


name: Device supply with programmed alert transmission for remote therapy response monitoring of cognitive behavior therapy, each 30 days


name: Device supply with scheduled recording and programmed alert transmission for remote therapeutic monitoring of cognitive behavior therapy, each 30 days


name: Device supply with scheduled recording and programmed alert transmission for remote therapy adherence monitoring of cognitive behavior therapy, each 30 days


name: Device supply with scheduled recording and programmed alert transmission for remote therapy response monitoring of cognitive behavior therapy, each 30 days


name: Device supply with scheduled recording for remote therapeutic monitoring of cognitive behavior therapy, each 30 days


name: Device supply with scheduled recording for remote therapy adherence monitoring of cognitive behavior therapy, each 30 days


name: Transperineal laser ablation of benign prostatic hyperplasia, including imaging guidance


name: Shockwave destruction of calcified plaque in coronary artery accessed through skin using catheter


name: Cardiac acoustic waveform recording with automated analysis and generation of coronary artery disease risk score


name: Autologous adipose-derived regenerative cell (ADRC) therapy for partial thickness rotator cuff tear


name: Autologous adipose-derived regenerative cell (ADRC) therapy for partial thickness rotator cuff tear; adipose tissue harvesting, isolation and preparation of harvested cells, including incubation with cell dissociation enzymes, filtration, washing, and concentration of ADRCs


name: Autologous adipose-derived regenerative cell (ADRC) therapy for partial thickness rotator cuff tear; injection into supraspinatus tendon including ultrasound guidance, unilateral


name: Posterior vertebral joint replacement, including bilateral facetectomy, laminectomy, and radical discectomy, including imaging guidance, lumbar spine, single segment


name: Replacement of posterior joint in single segment of spine in lower back (lumbar) using imaging guidance


name: Percutaneous electrical nerve field stimulation, cranial nerves, without implantation


name: Electrical nerve field stimulation of cranial nerves through skin


name: Quantitative computed tomography (CT) tissue characterization, including interpretation and report, obtained without concurrent CT examination of any structure contained in previously acquired diagnostic imaging


name: Quantitative computed tomography (CT scan) tissue characterization with interpretation and report


name: Quantitative computed tomography (CT) tissue characterization, including interpretation and report, obtained with concurrent CT examination of any structure contained in the concurrently acquired diagnostic imaging dataset (List separately in addition to code for primary procedure)


name: Quantitative magnetic resonance cholangiopancreatography (QMRCP), including data preparation and transmission, interpretation and report, obtained without diagnostic magnetic resonance imaging (MRI) examination of the same anatomy (eg, organ, gland, tissue, target structure) during the same session


name: Quantitative magnetic resonance (MR scan) imaging of gallbladder, bile ducts, pancreas and pancreatic duct cholangiopancreatography (QMRCP), with data preparation and transmission, interpretation and report


name: Quantitative magnetic resonance cholangiopancreatography (QMRCP), including data preparation and transmission, interpretation and report, obtained with diagnostic magnetic resonance imaging (MRI) examination of the same anatomy (eg, organ, gland, tissue, target structure) (List separately in addition to code for primary procedure)


name: Quantitative magnetic resonance (MR scan) imaging of gallbladder, bile ducts, pancreas and pancreatic duct cholangiopancreatography (QMRCP), with data preparation and transmission, interpretation and report and with diagnostic magnetic resonance imaging (MRI) examination of same anatomy


name: Implantation of vestibular nerve stimulation device in one ear


name: Removal of vestibular nerve stimulation device from one ear


name: Removal and replacement of vestibular nerve stimulation device from one ear


name: Diagnostic analysis of vestibular implant, unilateral


name: Diagnostic analysis of vestibular implant, unilateral; with initial programming


name: Diagnostic analysis and initial programming of vestibular nerve stimulation device in one ear


name: Diagnostic analysis of vestibular implant, unilateral; with subsequent programming


name: Trabeculotomy by laser, including optical coherence tomography (OCT) guidance


name: Laser incision of drainage tissue within eye (trabeculotomy) using optical coherence tomography (OCT) guidance


name: Augmentative AI-based facial phenotype analysis with report


name: Augmentative artificial intelligence-based analysis of facial features (facial phenotype) for possible genetic syndromes with report


name: Remote real-time, motion capture-based neurorehabilitative therapy ordered by a physician or other qualified health care professional


name: Remote real-time, motion capture-based neurorehabilitative therapy ordered by a physician or other qualified health care professional; supply and technical support, per 30 days


name: Device supply and technical support for remote real-time, motion capture-based neurorehabilitative therapy, per 30 days


name: Remote real-time, motion capture-based neurorehabilitative therapy ordered by a physician or other qualified health care professional; treatment management services by a physician or other qualified health care professional, per calendar month


name: Treatment management service for remote real-time, motion capture-based neurorehabilitative therapy, per calendar month


name: Preparation of tumor cavity, with placement of a radiation therapy applicator for intraoperative radiation therapy (IORT) concurrent with primary craniotomy (List separately in addition to code for primary procedure)


name: Colonic lavage, 35 or more liters of water, gravity-fed, with induced defecation, including insertion of rectal catheter


name: Treatment planning for magnetic field induction ablation of malignant prostate tissue, using data from previously performed magnetic resonance imaging (MRI) examination


name: Ablation of malignant prostate tissue by magnetic field induction, including all intraprocedural, transperineal needle/catheter placement for nanoparticle installation and intraprocedural temperature monitoring, thermal dosimetry, bladder irrigation, and magnetic field nanoparticle activation


name: Destruction of prostate cancer by magnetic field induction


name: Remote autonomous algorithm-based recommendation system for insulin dose calculation and titration


name: Remote autonomous algorithm-based recommendation system for insulin dose calculation and titration; initial set-up and patient education


name: Remote autonomous algorithm-based recommendation system for insulin dose calculation and titration; provision of software, data collection, transmission, and storage, each 30 days


name: Absolute quantitation of myocardial blood flow (AQMBF), single-photon emission computed tomography (SPECT), with exercise or pharmacologic stress, and at rest, when performed (List separately in addition to code for primary procedure)


name: SPECT measurement of blood flow to heart muscle


name: Bone strength and fracture risk using finite element analysis of functional data and bone mineral density (BMD), with concurrent vertebral fracture assessment, utilizing data from a computed tomography scan, retrieval and transmission of the scan data, measurement of bone strength and BMD and classification of any vertebral fractures, with overall fracture-risk assessment, interpretation and report


name: Bone strength and fracture-risk assessment with assessment for broken spine bones


name: Bone strength and fracture-risk assessment using digital X-ray radiogrammetry-bone mineral density (DXR-BMD) analysis of bone mineral density (BMD) utilizing data from a digital X ray, retrieval and transmission of digital X-ray data, assessment of bone strength and fracture risk and BMD, interpretation and report


name: Bone strength and fracture-risk assessment using digital X-ray radiogrammetry-bone mineral density (DXR-BMD)


name: Bone strength and fracture-risk assessment using digital X-ray radiogrammetry-bone mineral density (DXR-BMD) analysis of bone mineral density (BMD) utilizing data from a digital X ray, retrieval and transmission of digital X-ray data, assessment of bone strength and fracture risk and BMD, interpretation and report; with single-view digital X-ray examination of the hand taken for the purpose of DXR-BMD


name: Bone strength and fracture-risk assessment using digital X-ray radiogrammetry-bone mineral density (DXR-BMD) with single-view digital X-ray of hand


name: Insertion of bioprosthetic valve, open, femoral vein, including duplex ultrasound imaging guidance, when performed, including autogenous or nonautogenous patch graft (eg, polyester, ePTFE, bovine pericardium), when performed


name: Insertion of bioprosthetic valve in vein of thigh (femoral vein)


name: Cardiac focal ablation utilizing radiation therapy for arrhythmia


name: Cardiac focal ablation utilizing radiation therapy for arrhythmia; noninvasive arrhythmia localization and mapping of arrhythmia site (nidus), derived from anatomical image data (eg, CT, MRI, or myocardial perfusion scan) and electrical data (eg, 12-lead ECG data), and identification of areas of avoidance


name: Noninvasive localization and mapping of heart tissue causing abnormal heart rhythm for radiation treatment for focal destruction of arrhythmia site


name: Cardiac focal ablation utilizing radiation therapy for arrhythmia; conversion of arrhythmia localization and mapping of arrhythmia site (nidus) into a multidimensional radiation treatment plan


name: Cardiac focal ablation utilizing radiation therapy for arrhythmia; delivery of radiation therapy, arrhythmia


name: Injections of stem cell product into perianal perifistular soft tissue, including fistula preparation (eg, removal of setons, fistula curettage, closure of internal openings)


name: Injections of stem cell product into soft tissue around abnormal drainage tract next to anus


name: Digital Pathology Digitization Procedures


name: Digitization of glass microscope slides for level II, surgical pathology, gross and microscopic examination (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for level II surgical pathology


name: Digitization of glass microscope slides for level III, surgical pathology, gross and microscopic examination (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for level III surgical pathology


name: Digitization of glass microscope slides for level IV, surgical pathology, gross and microscopic examination (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for level IV surgical pathology


name: Digitization of glass microscope slides for level V, surgical pathology, gross and microscopic examination (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for level V surgical pathology


name: Digitization of glass microscope slides for level VI, surgical pathology, gross and microscopic examination (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for level VI surgical pathology


name: Digitization of glass microscope slides for special stain, including interpretation and report, group I, for microorganisms (eg, acid fast, methenamine silver) (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for Group I special stain for microorganisms


name: Digitization of glass microscope slides for special stain, including interpretation and report, group II, all other (eg, iron, trichrome), except stain for microorganisms, stains for enzyme constituents, or immunocytochemistry and immunohistochemistry (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for Group II special stain


name: Digitization of glass microscope slides for special stain, including interpretation and report, histochemical stain on frozen tissue block (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for special stain, including interpretation and report, group III, for enzyme constituents (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for Group III special stain


name: Digitization of glass microscope slides for immunohistochemistry or immunocytochemistry, per specimen, initial single antibody stain procedure (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for immunohistochemistry or immunocytochemistry, initial single antibody stain procedure


name: Digitization of glass microscope slides for immunohistochemistry or immunocytochemistry, per specimen, each additional single antibody stain procedure (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for immunohistochemistry or immunocytochemistry, each additional single antibody stain procedure


name: Digitization of glass microscope slides for immunohistochemistry or immunocytochemistry, per specimen, each multiplex antibody stain procedure (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for immunohistochemistry or immunocytochemistry, each multiplex antibody stain procedure


name: Digitization of glass microscope slides for morphometric analysis, tumor immunohistochemistry (eg, Her-2/neu, estrogen receptor/progesterone receptor), quantitative or semiquantitative, per specimen, each single antibody stain procedure, manual (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for morphometric analysis, tumor immunohistochemistry, each manual single antibody stain procedure


name: Assistive algorithmic electrocardiogram risk-based assessment for cardiac dysfunction (eg, low-ejection fraction, pulmonary hypertension, hypertrophic cardiomyopathy)


name: Assistive algorithmic electrocardiogram risk-based assessment for cardiac dysfunction (eg, low-ejection fraction, pulmonary hypertension, hypertrophic cardiomyopathy); related to concurrently performed electrocardiogram (List separately in addition to code for primary procedure)


name: Assistive algorithmic electrocardiogram risk-based assessment for cardiac dysfunction (eg, low-ejection fraction, pulmonary hypertension, hypertrophic cardiomyopathy); related to previously performed electrocardiogram


name: Transcutaneous magnetic stimulation by focused low-frequency electromagnetic pulse, peripheral nerve, initial treatment, with identification and marking of the treatment location, including noninvasive electroneurographic localization (nerve conduction localization), when performed


name: Transcutaneous magnetic stimulation by focused low-frequency electromagnetic pulse, peripheral nerve, initial treatment, with identification and marking of the treatment location, including noninvasive electroneurographic localization (nerve conduction localization), when performed; first nerve


name: Transcutaneous magnetic stimulation of peripheral nerve by focused low-frequency electromagnetic pulse, initial treatment on first nerve


name: Transcutaneous magnetic stimulation by focused low-frequency electromagnetic pulse, peripheral nerve, initial treatment, with identification and marking of the treatment location, including noninvasive electroneurographic localization (nerve conduction localization), when performed; each additional nerve (List separately in addition to code for primary procedure)


name: Transcutaneous magnetic stimulation of peripheral nerve by focused low-frequency electromagnetic pulse, initial treatment on additional nerve


name: Transcutaneous magnetic stimulation by focused low-frequency electromagnetic pulse, peripheral nerve, subsequent treatment, including noninvasive electroneurographic localization (nerve conduction localization), when performed


name: Transcutaneous magnetic stimulation by focused low-frequency electromagnetic pulse, peripheral nerve, subsequent treatment, including noninvasive electroneurographic localization (nerve conduction localization), when performed; first nerve


name: Transcutaneous magnetic stimulation of peripheral nerve by focused low-frequency electromagnetic pulse, subsequent treatment on first nerve


name: Transcutaneous magnetic stimulation by focused low-frequency electromagnetic pulse, peripheral nerve, subsequent treatment, including noninvasive electroneurographic localization (nerve conduction localization), when performed; each additional nerve (List separately in addition to code for primary procedure)


name: Transcutaneous magnetic stimulation of peripheral nerve by focused low-frequency electromagnetic pulse, subsequent treatment on additional nerve


name: Virtual reality technology to assist therapy (List separately in addition to code for primary procedure)


name: Virtual Reality Patient Procedural Dissociation


name: Virtual reality (VR) procedural dissociation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the VR procedural dissociation supports, requiring the presence of an independent, trained observer to assist in the monitoring of the patient's level of dissociation or consciousness and physiological status


name: Virtual reality (VR) procedural dissociation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the VR procedural dissociation supports, requiring the presence of an independent, trained observer to assist in the monitoring of the patient's level of dissociation or consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older


name: Virtual reality (VR) procedural dissociation services provided by same health care professional performing diagnostic or therapeutic procedure VR procedural dissociation supports, initial 15 minutes, patient age 5 years or older


name: Virtual reality (VR) procedural dissociation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the VR procedural dissociation supports, requiring the presence of an independent, trained observer to assist in the monitoring of the patient's level of dissociation or consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service)


name: Virtual reality (VR) procedural dissociation services provided by same health care professional performing diagnostic or therapeutic procedure VR procedural dissociation supports, additional 15 minutes


name: Virtual reality (VR) procedural dissociation services provided by a physician or other qualified health care professional other than the physician or other qualified health care professional performing the diagnostic or therapeutic service that the VR procedural dissociation supports


name: Virtual reality (VR) procedural dissociation services provided by a physician or other qualified health care professional other than the physician or other qualified health care professional performing the diagnostic or therapeutic service that the VR procedural dissociation supports; initial 15 minutes of intraservice time, patient age 5 years or older


name: Virtual reality (VR) procedural dissociation services provided by different health care professional than health care professional performing diagnostic or therapeutic procedure VR procedural dissociation supports, initial 15 minutes, patient age 5 years or older


name: Virtual reality (VR) procedural dissociation services provided by a physician or other qualified health care professional other than the physician or other qualified health care professional performing the diagnostic or therapeutic service that the VR procedural dissociation supports; each additional 15 minutes intraservice time (List separately in addition to code for primary service)


name: Virtual reality (VR) procedural dissociation services provided by different health care professional than health care professional performing diagnostic or therapeutic procedure VR procedural dissociation supports, additional 15 minutes


name: Arthrodesis, sacroiliac joint, percutaneous, with image guidance, includes placement of intra-articular implant(s) (eg, bone allograft[s], synthetic device[s])


name: Fusion of sacroiliac joint between spine and pelvis with bone graft, accessed through skin using imaging guidance


name: Therapeutic induction of intra-brain hypothermia, including placement of a mechanical temperature-controlled cooling device to the neck over carotids and head, including monitoring (eg, vital signs and sport concussion assessment tool 5 [SCAT5]), 30 minutes of treatment


name: Therapeutic induction of low temperature in brain, 30 minutes of treatment


name: Real-time pressure-sensing epidural guidance system (List separately in addition to code for primary procedure)


name: Office-Based Measurement of Mechanomyography and Inertial Measurement Units


name: Surface mechanomyography (sMMG) with concurrent application of inertial measurement unit (IMU) sensors for measurement of multi-joint range of motion, posture, gait, and muscle function


name: Surface mechanomyography (sMMG) with application of inertial measurement unit (IMU) sensors for measurement of multi-joint range of motion, posture, gait, and muscle function


name: Gastrointestinal myoelectrical activity study, stomach through colon, with interpretation and report


name: Study of gastrointestinal muscle electric activity of stomach through large intestine


name: Instillation of fecal microbiota suspension via rectal enema into lower gastrointestinal tract


name: Bronchoscopy, rigid or flexible, with insertion of esophageal protection device and circumferential radiofrequency destruction of the pulmonary nerves, including fluoroscopic guidance when performed


name: Bronchoscopy, rigid or flexible, with insertion of esophageal protection device and circumferential radiofrequency destruction of the pulmonary nerves, including fluoroscopic guidance when performed; bilateral mainstem bronchi


name: Insertion of protection device in esophagus and radiofrequency destruction of nerves to lung in mainstem airway on one side of body using endoscope


name: Bronchoscopy, rigid or flexible, with insertion of esophageal protection device and circumferential radiofrequency destruction of the pulmonary nerves, including fluoroscopic guidance when performed; unilateral mainstem bronchus


name: Insertion of protection device in esophagus and radiofrequency destruction of nerves to lung in both mainstem airways using endoscope


name: Transcutaneous auricular neurostimulation, set-up, calibration, and patient education on use of equipment


name: Synchronous Telemedicine Service Rendered Via Telephone or Other Real-Time Interactive Audio-Only Telecommunications System


name: Artificial Intelligence Taxonomy for Medical Services and Procedures


name: CPT Codes That May Be Used For Synchronous Real-Time Interactive Audio-Only Telemedicine Services


name: Initial Hospital Inpatient or Observation Care (Add-on Table)


name: Subsequent Hospital Inpatient or Observation Care (Add-on Table)


name: Hospital Inpatient or Observation Care Services (Including Admission and Discharge Services) (Add-on Table)


name: Inpatient or Observation Consultations (Add-on Table)


name: Home or Residence Services (New Patient) (Add-on Table)


name: Home or Residence Services (Established Patient) (Add-on Table)


name: Use of Anti-Piracy Technology in CPT Professional 2023 Codebook


name: Repair of nasal valve collapse with low-energy temperature-controlled radiofrequency submucosal remodeling


name: Heart-type fatty acid-binding protein (procedure)


name: HUGO Gene Nomenclature Committee (organization)


name: VTSL Spanish language reference set (metadata)


name: Pelvic Fascia-Sparing Radical Prostatectomy


name: American Joint Committee on Cancer ypT1 (qualifier value)


name: sports medicine outpatient progress note


name: systolic blood pressure at first encounter


name: thromboembolism outpatient progress note


name: total vaccine doses distributed per 100,000 population


name: transplant surgery outpatient progress note


name: vascular neurology hospital progress note


name: vascular neurology outpatient progress note


name: vascular surgery outpatient progress note


name: wound care management hospital progress note


name: wound care management outpatient progress note


name: American Joint Committee on Cancer stage IA2 (qualifier value)


name: American Joint Committee on Cancer R0 (qualifier value)


name: American Joint Committee on Cancer stage IB2 (qualifier value)


name: American Joint Committee on Cancer grade GX (qualifier value)


name: American Joint Committee on Cancer pTX (qualifier value)


name: American Joint Committee on Cancer pT4c (qualifier value)


name: American Joint Committee on Cancer cM1 (qualifier value)


name: American Joint Committee on Cancer cN1b (qualifier value)


name: American Joint Committee on Cancer pN2c (qualifier value)


name: American Joint Committee on Cancer pN1 (qualifier value)


name: American Joint Committee on Cancer grade G4 (qualifier value)


name: American Joint Committee on Cancer cT3 (qualifier value)


name: American Joint Committee on Cancer pT3b (qualifier value)


name: American Joint Committee on Cancer pT4a (qualifier value)


name: American Joint Committee on Cancer pN2 (qualifier value)


name: American Joint Committee on Cancer cN3 (qualifier value)


name: American Joint Committee on Cancer pT4d (qualifier value)


name: Concentrate for conventional release cutaneous solution (dose form)


name: Injury Severity Score (observable entity)


name: American Joint Committee on Cancer stage IV:1 (qualifier value)


name: American Joint Committee on Cancer stage IV:7 (qualifier value)


name: American Joint Committee on Cancer pN3a (qualifier value)


name: American Joint Committee on Cancer cN1 (qualifier value)


name: American Joint Committee on Cancer cNX (qualifier value)


name: American Joint Committee on Cancer cT1 (qualifier value)


name: American Joint Committee on Cancer grade G1


name: American Joint Committee on Cancer grade G2


name: American Joint Committee on Cancer grade G3


name: microsurgical epididymal sperm aspiration


name: interventional radiology outpatient progress note


name: maternal and fetal medicine hospital progress note


name: maternal and fetal medicine outpatient progress note


name: maternal and fetal medicine telephone encounter note


name: medical aid in dying hospital progress note


name: medical aid in dying outpatient progress note


name: neurological surgery hospital progress note


name: neurological surgery outpatient progress note


name: neurology with special qualifications in child neurology hospital progress note


name: neurology with special qualifications in child neurology outpatient progress note


name: nurse practitioner hospital progress note


name: nurse practitioner outpatient progress note


name: nutrition and dietetics hospital progress note


name: nutrition and dietetics outpatient progress note


name: obstetrics and gynecology hospital progress note


name: obstetrics and gynecology outpatient progress note


name: occupational therapy hospital progress note


name: American Joint Committee on Cancer cN1a (qualifier value)


name: American Joint Committee on Cancer R2 (qualifier value)


name: American Joint Committee on Cancer RX (qualifier value)


name: American Joint Committee on Cancer cT2 (qualifier value)


name: American Joint Committee on Cancer pT0 (qualifier value)


name: American Joint Committee on Cancer pT2b (qualifier value)


name: American Joint Committee on Cancer pN3b (qualifier value)


name: American Joint Committee on Cancer pN3c (qualifier value)


name: American Joint Committee on Cancer pT4b (qualifier value)


name: American Joint Committee on Cancer pM1b (qualifier value)


name: American Joint Committee on Cancer pN1a (qualifier value)


name: American Joint Committee on Cancer pN1b (qualifier value)


name: American Joint Committee on Cancer cN2 (qualifier value)


name: American Joint Committee on Cancer pT1a (qualifier value)


name: American Joint Committee on Cancer pT2a (qualifier value)


name: American Joint Committee on Cancer pT2c (qualifier value)


name: American Joint Committee on Cancer pT3a (qualifier value)


name: American Joint Committee on Cancer stage IB1 (qualifier value)


name: American Joint Committee on Cancer pM1a (qualifier value)


name: American Joint Committee on Cancer pM1c (qualifier value)


name: American Joint Committee on Cancer grade G5 (qualifier value)


name: {1 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG Oral Capsule) / 1 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack


name: Cold and Flu Non Drowsy Daytime and Nighttime KIT


name: ethinyl estradiol-norgestimate triphasic (0.025 mg-0.18 mg)-(0.025 mg-0.215 mg)-(0.025 mg-0.25 mg) oral tablet


name: American Joint Committee on Cancer stage I (qualifier value)


name: American Joint Committee on Cancer stage IA (qualifier value)


name: American Joint Committee on Cancer stage IA1


name: American Joint Committee on Cancer stage IB


name: American Joint Committee on Cancer stage IC


name: American Joint Committee on Cancer stage III


name: American Joint Committee on Cancer stage IIIA


name: Insertion of complete fixed orthodontic appliance


name: Insertion of fixed orthodontic appliance


name: American Joint Committee on Cancer stage IVA


name: American Joint Committee on Cancer stage IVC


name: American Joint Committee on Cancer grade LG


name: MRI of tibiocalcaneal ligaments of both ankles


name: MRI of posterior tibiotalar ligaments of both ankles


name: MRI of tibionavicular ligaments of both ankles


name: multi-specialty program hospital progress note


name: multi-specialty program outpatient progress note


name: occupational therapy outpatient progress note


name: oral and maxillofacial surgery hospital progress note


name: oral and maxillofacial surgery outpatient progress note


name: orthotics prosthetics hospital progress note


name: orthotics prosthetics outpatient progress note


name: outpatient COVID-19 intubation progress note


name: neonatal perinatal medicine hospital progress note


name: neonatal perinatal medicine outpatient progress note


name: adolescent medicine hospital progress note


name: adolescent medicine outpatient progress note


name: palliative care outpatient progress note


name: pediatric cardiology hospital progress note


name: pediatric cardiology outpatient progress note


name: pediatric dermatology hospital progress note


name: pediatric dermatology outpatient progress note


name: pediatric endocrinology hospital progress note


name: pediatric endocrinology outpatient progress note


name: pediatric gastroenterology hospital progress note


name: pediatric gastroenterology outpatient progress note


name: pediatric infectious diseases hospital progress note


name: American Joint Committee on Cancer stage I:0


name: American Joint Committee on Cancer stage IV:0


name: Apol1 (apolipoprotein l1) (eg, chronic kidney disease), risk variants (g1, g2) test


name: Intravenous injection, bebtelovimab, includes injection and post administration monitoring


name: HCPCS Version of Current Dental Terminology (CDT), 2023


name: {40 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 196 - 200 KG]


name: {11 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 51 - 55 KG]


name: {15 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 71 - 75 KG]


name: {24 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 116 - 120 KG]


name: {45 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 221 - 225 KG]


name: {10 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 46 - 50 KG]


name: {17 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 81 - 85 KG]


name: {19 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 91 - 95 KG]


name: {23 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 111 - 115 KG]


name: {25 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 121 - 125 KG]


name: {36 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 176 - 180 KG]


name: {37 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 181 - 185 KG]


name: {39 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 191 - 195 KG]


name: {43 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 211 - 215 KG]


name: Cumulative Illness Rating Scale for Geriatrics Clinical Classification


name: American Joint Committee on Cancer pN3 (qualifier value)


name: allergy and immunology hospital progress note


name: allergy and immunology outpatient progress note


name: pediatric infectious diseases outpatient progress note


name: pediatric otolaryngology hospital progress note


name: pediatric otolaryngology outpatient progress note


name: pediatric pulmonology hospital progress note


name: pediatric pulmonology outpatient progress note


name: pediatric rheumatology hospital progress note


name: pediatric rheumatology outpatient progress note


name: pediatric surgery hospital progress note


name: pediatric surgery outpatient progress note


name: pediatric transplant hepatology hospital progress note


name: pediatric transplant hepatology outpatient progress note


name: pediatric urology outpatient progress note


name: pharmacogenomics outpatient progress note


name: physical medicine and rehab hospital progress note


name: physical medicine and rehab outpatient progress note


name: Growth hormone receptor agonist (disposition)


name: {44 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 216 - 220 KG]


name: {14 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 66 - 70 KG]


name: {20 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 96 - 100 KG]


name: {46 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 226 - 230 KG]


name: {27 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 131 - 135 KG]


name: {30 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 146 - 150 KG]


name: {35 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 171 - 175 KG]


name: {32 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 156 - 160 KG]


name: {12 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 56 - 60 KG]


name: {48 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 236 - 240 KG]


name: {42 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 206 - 210 KG]


name: {31 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 151 - 155 KG]


name: {29 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 141 - 145 KG]


name: {18 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 86 - 90 KG]


name: {16 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 76 - 80 KG]


name: {26 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 126 - 130 KG]


name: {33 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 161 - 165 KG]


name: {13 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 61 - 65 KG]


name: {21 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 101 - 105 KG]


name: {22 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 106 - 110 KG]


name: {28 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 136 - 140 KG]


name: {47 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 231 - 235 KG]


name: {34 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 166 - 170 KG]


name: {38 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 186 - 190 KG]


name: {41 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix]) } Pack [Hemgenix Kit 201 - 205 KG]


name: Aspiration of bone marrow from tibial tuberosity


name: American Joint Committee on Cancer stage 0


name: American Joint Committee on Cancer stage I:1


name: American Joint Committee on Cancer stage I:10


name: American Joint Committee on Cancer stage I:11


name: American Joint Committee on Cancer stage I:12


name: American Joint Committee on Cancer stage I:14


name: American Joint Committee on Cancer stage I:15


name: American Joint Committee on Cancer stage I:16


name: American Joint Committee on Cancer stage I:18


name: American Joint Committee on Cancer stage I:2


name: American Joint Committee on Cancer stage I:20


name: American Joint Committee on Cancer stage I:24


name: American Joint Committee on Cancer stage I:25


name: American Joint Committee on Cancer stage I:3


name: American Joint Committee on Cancer stage I:4


name: bariatric surgery hospital progress note


name: bariatric surgery outpatient progress note


name: blood banking and transfusion medicine hospital progress note


name: blood banking and transfusion medicine outpatient progress note


name: bone marrow transplant hospital progress note


name: bone marrow transplant outpatient progress note


name: burn management outpatient progress note


name: cardiac surgery outpatient progress note


name: physical therapy outpatient progress note


name: plasma cells/100 leukocytes in synovial fluid


name: plastic surgery outpatient progress note


name: Sunlenca 300 MG Oral Tablet includes 4-Tablet Pack & 5-Tablet Pack


name: American Joint Committee on Cancer stage I:7


name: American Joint Committee on Cancer stage I:8


name: American Joint Committee on Cancer stage I:9


name: American Joint Committee on Cancer stage II:1


name: American Joint Committee on Cancer stage II:10


name: American Joint Committee on Cancer stage II:15


name: American Joint Committee on Cancer stage II:16


name: American Joint Committee on Cancer stage II:17


name: American Joint Committee on Cancer stage II:18


name: American Joint Committee on Cancer stage II:19


name: American Joint Committee on Cancer stage II:2


name: American Joint Committee on Cancer stage II:20


name: American Joint Committee on Cancer stage II:24


name: American Joint Committee on Cancer stage II:25


name: American Joint Committee on Cancer stage II:3


name: American Joint Committee on Cancer stage II:4


name: American Joint Committee on Cancer stage II:5


name: American Joint Committee on Cancer stage II:6


name: American Joint Committee on Cancer stage II:7


name: American Joint Committee on Cancer stage II:8


name: American Joint Committee on Cancer stage II:9


name: American Joint Committee on Cancer stage IIA


name: American Joint Committee on Cancer stage IIB


name: American Joint Committee on Cancer stage III:0


name: American Joint Committee on Cancer stage III:1


name: American Joint Committee on Cancer stage III:10


name: American Joint Committee on Cancer stage III:12


name: American Joint Committee on Cancer stage III:13


name: American Joint Committee on Cancer stage III:16


name: child and adolescent psychiatry hospital progress note


name: child and adolescent psychiatry outpatient progress note


name: chiropractic medicine outpatient progress note


name: clinical cardiac electrophysiology hospital progress note


name: clinical cardiac electrophysiology outpatient progress note


name: clinical genetics hospital progress note


name: clinical genetics outpatient progress note


name: clinical neurophysiology hospital progress note


name: clinical neurophysiology outpatient progress note


name: clinical pathology hospital progress note


name: clinical pathology outpatient progress note


name: {1 (sodium phenylbutyrate 3000 MG Granules for Oral Suspension [Olpruva]) } Pack [Olpruva 3 GM Pack]


name: SARS-CoV-2 Spike Receptor Binding Domain


name: American Joint Committee on Cancer stage III:2


name: American Joint Committee on Cancer stage III:20


name: American Joint Committee on Cancer stage III:22


name: American Joint Committee on Cancer stage III:24


name: American Joint Committee on Cancer stage III:25


name: American Joint Committee on Cancer stage III:3


name: American Joint Committee on Cancer stage III:4


name: American Joint Committee on Cancer stage III:5


name: American Joint Committee on Cancer stage III:6


name: American Joint Committee on Cancer stage III:7


name: American Joint Committee on Cancer stage III:8


name: American Joint Committee on Cancer stage III:9


name: American Joint Committee on Cancer stage IIIB


name: American Joint Committee on Cancer stage IIIC


name: American Joint Committee on Cancer stage IIID


name: American Joint Committee on Cancer stage IV:14


name: American Joint Committee on Cancer stage IV:15


name: American Joint Committee on Cancer stage IV:17


name: American Joint Committee on Cancer stage IV:2


name: American Joint Committee on Cancer stage IV:20


name: American Joint Committee on Cancer stage IV:25


name: American Joint Committee on Cancer stage IV:3


name: American Joint Committee on Cancer stage IV:4


name: American Joint Committee on Cancer stage IV:5


name: American Joint Committee on Cancer stage IV:6


name: American Joint Committee on Cancer stage IV:8


name: American Joint Committee on Cancer stage IV:9


name: American Joint Committee on Cancer stage IVB


name: colon and rectal surgery hospital progress note


name: colon and rectal surgery outpatient progress note


name: Administration of coronavirus vaccine 25, reserved


name: Administration of coronavirus vaccine 24, reserved


name: {2 (sodium phenylbutyrate 3000 MG Granules for Oral Suspension [Olpruva]) } Pack [Olpruva 6 GM Pack]


name: {1 (sodium phenylbutyrate 2000 MG Granules for Oral Suspension [Olpruva]) } Pack [Olpruva 2 GM Pack]


name: {1 (sodium phenylbutyrate 3000 MG Granules for Oral Suspension [Olpruva]) / 1 (sodium phenylbutyrate 3670 MG Granules for Oral Suspension [Olpruva]) } Pack [Olpruva 6.67 GM Pack]


name: {1 (sodium phenylbutyrate 2000 MG Granules for Oral Suspension [Olpruva]) / 1 (sodium phenylbutyrate 3000 MG Granules for Oral Suspension [Olpruva]) } Pack [Olpruva 5 GM Pack]


name: {2 (sodium phenylbutyrate 2000 MG Granules for Oral Suspension [Olpruva]) } Pack [Olpruva 4 GM Pack]


name: dialysis and therapeutic apheresis hospital progress note


name: dialysis and therapeutic apheresis outpatient progress note


name: drainage of left maxillary sinus (treatment)


name: drainage of right maxillary sinus (treatment)


name: eating disorders outpatient progress note


name: family medicine outpatient progress note


name: gastroenterology outpatient progress note


name: geriatric medicine hospital progress note


name: geriatric medicine outpatient progress note


name: gynecologic oncology hospital progress note


name: gynecologic oncology outpatient progress note


name: healthcare navigator hospital progress note


name: American Joint Committee on Cancer grade GB


name: Activities-Specific Balance Confidence Scale Questionnaire


name: Tanner Pubic Hair Development Stage 1, Female


name: Tanner Pubic Hair Development Stage 1, Male


name: Tanner Pubic Hair Development Stage 2, Female


name: Tanner Pubic Hair Development Stage 2, Male


name: Tanner Pubic Hair Development Stage 3, Female


name: Tanner Pubic Hair Development Stage 3, Male


name: Tanner Pubic Hair Development Stage 4, Male


name: Tanner Pubic Hair Development Stage 4, Female


name: Tanner Pubic Hair Development Stage 5, Male


name: American Joint Committee on Cancer grade HG


name: healthcare navigator outpatient progress note


name: hospital COVID-19 intubation progress note


name: Tanner Pubic Hair Development Stage 5, Female


name: infectious disease hospital progress note


name: infectious disease outpatient progress note


name: internal medicine hospital progress note


name: internal medicine outpatient progress note


name: interventional cardiology hospital progress note


name: interventional cardiology outpatient progress note


name: interventional radiology hospital progress note


name: interventional radiology outpatient note


name: radiation oncology hospital progress note


name: radiation oncology outpatient progress note


name: rapid response team hospital progress note


name: recreational therapy hospital progress note


name: recreational therapy outpatient progress note


name: reproductive endocrinology and infertility hospital progress note


name: reproductive endocrinology and infertility outpatient progress note


name: solid organ transplant hospital progress note


name: solid organ transplant outpatient progress note


name: ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY 18 g in 100 g TOPICAL STICK [Old Spice Oasis with Vanilla Notes]


name: ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY 18 g in 100 g TOPICAL STICK [Secret Spring Breeze Invisible Antiperspirant/Deodorant]


name: ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY 17 g in 100 g TOPICAL STICK [Old Spice Fresh High Endurance Antiperspirant and Deodorant]


name: OCTISALATE 4.9 g in 100 mL / AVOBENZONE 2.9 g in 100 mL / HOMOSALATE 9.8 g in 100 mL / OCTOCRYLENE 9.5 g in 100 mL TOPICAL SPRAY [Habit SPF 39 White Peach and Neroli Mister]


name: OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / HOMOSALATE 150 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL SPRAY [Walgreens SPF 70 Sport Continuous]


name: OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / HOMOSALATE 150 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL SPRAY [Wegmans Sport Broad Spectrum SPF 70 Clear Continuous Sunscreen]


name: OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / HOMOSALATE 150 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL SPRAY [Big Lots Soundbody SPF 70 Sport Sunscreen]


name: OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / HOMOSALATE 150 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL SPRAY [Exchange Select Sport Sunscreen Continuous SPF 70]


name: OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / HOMOSALATE 150 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL SPRAY [Family Dollar Tropic Sun SPF 70 Sport Sunscreen]


name: OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / HOMOSALATE 150 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL SPRAY [Market Basket Continuous Sunscreen General Protection SPF 70]


name: Titanium Dioxide 40 mg in 1 g / Zinc Oxide 55 mg in 1 g TOPICAL STICK [TiZO Mineral Stick - Tinted SPF 45]


name: Titanium Dioxide 40 mg in 1 g / Zinc Oxide 55 mg in 1 g TOPICAL STICK [TiZO Mineral Stick Non-Tinted SPF 45]


name: OCTINOXATE 7 g in 100 mL / ZINC OXIDE 6 g in 100 mL TOPICAL LOTION [STAY HOT BURN NOT Broad Spectrum SPF 25 Sunscreen]


name: TITANIUM DIOXIDE 3.5 g in 100 mL / ZINC OXIDE 9.5 g in 100 mL TOPICAL CREAM [Eezysun SPF50 Babies and Kids]


name: TITANIUM DIOXIDE 4.54 mg in 100 mg / ZINC OXIDE 3.49 mg in 100 mg TOPICAL CREAM [Cream]


name: TITANIUM DIOXIDE 41 mg in 1 mL / ZINC OXIDE 41 mg in 1 mL TOPICAL LOTION [Austalian Gold Broad Spectrum SPF 50 Sunscreen]


name: TITANIUM DIOXIDE 41.6 mg in 1 mL / ZINC OXIDE 41.6 mg in 1 mL TOPICAL LOTION [Australian Gold Broad Spectrum SPF 50 Sunscreen]


name: ZINC OXIDE 15.2 g in 100 mL TOPICAL LOTION [Versed Guards Up Daily Mineral Sunscreen Broad Spectrum SPF 35]


name: ZINC OXIDE 43.04 mg in 1 mL / TITANIUM DIOXIDE 43.04 mg in 1 mL TOPICAL LOTION [Australian Gold Botanical Tinted Face Mineral Sunscreen Broad Spectrum SPF 50]


name: ZINC OXIDE 209 g in 950 g TOPICAL LOTION [Bright Guard Natural SPF 30]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 19 g in 100 g TOPICAL STICK [Secret Cozy Vanilla Invisible]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g TOPICAL SPRAY [Sun Bum Kids Sunscreen SPF 50]


name: LANOLIN 249.1 mg in 1 g / AVOBENZONE 25 mg in 1 g / OCTINOXATE 70 mg in 1 g TOPICAL OINTMENT [Sun Protection]


name: ZINC OXIDE 197 mg in 1 g TOPICAL STICK [Babo Botanicals Super Shield Sport Sunscreen SPF 50]


name: ZINC OXIDE 17.5 g in 100 g TOPICAL SPRAY [doTERRA sun]


name: ZINC OXIDE 190 mg in 1 mL TOPICAL CREAM [Solaire peau Parfaite Mineral Screen SPF 30]


name: TRACH TUBE,SZ 6 CUFFLESS BIVONA SMITHS #60A160


name: CATHETER,INTERMITTENT 12FR FEMALE COLOPLAST #28812


name: DRESSING,ECLYPSE SUPER ABSORBENT #CR3818


name: DRESSING,EXUFIBER AG PLUS,0.8IN X 17.7IN #603420


name: DRESSING,EXUFIBER 0.8IN X 17.7IN #709909


name: DRESSING,TEGADERM ISLAND 2 3/8IN X 4IN 3M#3584


name: SUCTION TUBE ATTACHMENT DEVICE SAGE #6435


name: TUBE FEEDING SET,EXTENSION ENFIT AMT #8-1221-ISOSAF


name: CATHETER,FOLEY SILICONE DOVER 24FR 30ML COVIDIEN #8887630245


name: FEEDING BAG W/PUMP SET ENTERALITE INFINITY #INF1200-E


name: ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY 15 g in 100 g TOPICAL STICK [Secret Shower Fresh Antiperspirant and Deodorant Wide]


name: TRIPELENNAMINE HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 19 g in 100 g TOPICAL STICK [Secret Outlast Shower Fresh Invisible]


name: CIPROFLOXACIN 1 g in 1 g NOT APPLICABLE POWDER


name: FURAZOLIDONE 1 kg in 1 kg NOT APPLICABLE POWDER


name: LEVOMENTHOL 0.3 g in 100 mL / Salicylic Acid 0.25 g in 100 mL / Dexpanthenol 0.2 g in 100 mL TOPICAL LIQUID [CH6 Scalp Ssag Serum Red Edition]


name: Niacinamide 0.02 g / Adenosine 0.0004 g TOPICAL PATCH [LAPCOS SUNTIAGING EYE ZONE COOLING GOLF PAT CH S]


name: Niacinamide 2.0 g in 100 g / Adenosine 0.04 g in 100 g TOPICAL LIQUID [JAUNKYEOL AC Spot Treatment Balm]


name: Panthenol 0.2 g in 100 mL / Salicylic Acid 0.2 g in 100 mL / Niacinamide 0.1 g in 100 mL TOPICAL SHAMPOO [CH6 Color Change Black Aloforthya]


name: AVOBENZONE 2.0 g in 100 g / OCTINOXATE 6.5 g in 100 g / OCTISALATE 5.0 g in 100 g / OCTOCRYLENE 1.5 g in 100 g TOPICAL STICK [Beeswax Lip Balm]


name: TITANIUM DIOXIDE 10 g in 100 g / OCTINOXATE 5 g in 100 g TOPICAL CREAM


name: RID Home Lice, Bedbug And Dust Mite Spray, 0.5% topical spray


name: Alex Adjustable Sparkle Folding Cane - Red


name: Alex Offset Handle Aluminum Cane - Bronze


name: Always Anti-Bunch Liners Xtra Protection Long


name: Always Daily Liners Xtra Protection Long


name: Always Discreet Underwear Sensitive Skin L


name: Always Ultra Thin Long Super Pads Size 2


name: Always Ultra Thin Size 3 Extra Long Pads


name: Always ZZZ Disposable Period Underwear L/XL


name: Always ZZZ Period Underwear Light Scent S/M


name: Fixodent Plus Superior Hold Scope Flavor


name: Fixodent Plus bacteria Guard Denture Adhesive


name: Fixodent Ultra Max Hold Denture Adhesive


name: Garnier Nutrisse Dark Chocolate 40 Haircolor


name: Garnier Nutrisse Nourishing Color Creme 60


name: Norforms Tropical Splash Deo Suppositorie


name: Oral-B Glide Pro Health Deep Clean Floss 40m


name: Oral-B Glide Pro Health Original Floss 100m


name: Oral-B Glide Pro Health Original Floss 50m


name: Oral-B Glide Prohealth Comfort Plus Floss 40m


name: Oral-B Pulsar 3D White Luxe Pulsar Toothbrush


name: Sea-Bond Original Denture Adhesive Seals


name: Summer'S Eve Date Nght Alluring Evening Cloth


name: Summer'S Eve Fragrance Free Cleansing Cloths


name: Summer'S Eve Sunset Oasis Cleansing Cloth


name: Summer's Eve Blissfull Escape Cleansing Cloth


name: Summer's Eve Golden Glamour Cleansing Cloths


name: Summer's Eve Island Splash Cleansing Cloth


name: Summer's Eve Sheer Floral Cleansing Cloth


name: Tampax Cardboard Applicator Tampons Super


name: Tampax Pearl Unscented Triple Pack Tampons


name: Tampax Pocket Pearl Regular Compact Tampons


name: Tampax Radiant Unscented Regular Tampons


name: Tampax Tampon Regular Cardboard Applicator


name: RID Home Lice, Bedbug And Dust Mite Spray


name: Homosalate 90 mg in 1 mL / Octisalate 45 mg in 1 mL / Zinc Oxide 78 mg in 1 mL TOPICAL CREAM [Buildable Blur CC Broad Spectrum SPF 40 Sunscreen]


name: CarePoint 1mL 23G 1 inch Luer Lock Syringe with Safety Needle


name: CarePoint 1mL 25G 1 inch Luer Lock Syringe with Safety Needle


name: CarePoint 3mL 23G 1 inch Luer Lock Syringe with Safety Needle


name: CarePoint 3mL 25G 1 inch Luer Lock Syringe with Safety Needle


name: CarePoint 3mL 25G 5/8 inch Luer Lock Syringe with Safety Needle


name: ATP Ignite Effervescent Stick Pack (Mixed Berries)


name: Eucerin Advanced Repair Light Feel Topical Foot Creme


name: Hartig Drug 29G 1/2 inch Unifine Pentips


name: Hartig Drug 31G 3/16 inch Unifine Pentips


name: Hartig Drug 31G 5/16 inch Unifine Pentips


name: Hartig Drug 32G 1/4 inch Unifine Pentips


name: Hartig Drug 32G 5/32 inch Unifine Pentips


name: Pure Comfort Adult Inhaler Spacer Chamber


name: Quality Choice Unifine Pentips 29G 1/2 inch Pen Needle


name: Quality Choice Unifine Pentips 31G 1/4 inch Pen Needle


name: Quality Choice Unifine Pentips 31G 5/16 inch Pen Needle


name: Quality Choice Unilet Ultra Thin Lancet 28G


name: TRISEON 0.15g/0.5g Topical Cream Compounding Kit


name: i5 Functional Food Nutritional Powder for Suspension (Creamy Chocolate)


name: AVOBENZONE 2.0 g in 100 g / OCTINOXATE 6.5 g in 100 g / OCTISALATE 5.0 g in 100 g / OCTOCRYLENE 1.5 g in 100 g TOPICAL STICK [Peppermint Lip Balm]


name: AVOBENZONE 29.07 mg in 1 mL / OCTISALATE 48.45 mg in 1 mL / OCTOCRYLENE 48.45 mg in 1 mL / HOMOSALATE 96.9 mg in 1 mL TOPICAL LOTION [Panama Jack Broad Spectrum SPF 50]


name: AVOBENZONE 29.43 mg in 1 mL / HOMOSALATE 98.1 mg in 1 mL / OCTISALATE 49.1 mg in 1 mL / OCTOCRYLENE 49.1 mg in 1 mL TOPICAL LOTION [Australian Gold Broad Spectrum SPF 50]


name: OCTINOXATE 7 mg in 100 mL / OCTISALATE 5 mg in 100 mL / HOMOSALATE 3 mg in 100 mL TOPICAL LOTION [skin MD]


name: Octocrylene 80 mg in 1 mL / Homosalate 50 mg in 1 mL / Avobenzone 30 mg in 1 mL / Octisalate 30 mg in 1 mL TOPICAL LOTION [Powerbright Moisturizer SPF 50]


name: amino acids/protein hydrolysate 0.4 gram-3.6 kcal/gram ORAL POWDER IN PACKET (EA)


name: aminoprop ethy/oxybenzone/octinoxate/octocrylene/octyl salic 20 %-SPF 30 TOPICAL AEROSOL, SPRAY (ML)


name: diethyltoluamide 20 % TOPICAL LOTION, EXTENDED RELEASE (ML)


name: diethyltoluamide 25 % TOPICAL TOWELETTE (EA)


name: diethyltoluamide 29 % TOPICAL AEROSOL, SPRAY (GRAM)


name: diethyltoluamide 30 % TOPICAL TOWELETTE (EA)


name: diethyltoluamide 7 % TOPICAL AEROSOL, SPRAY (GRAM)


name: diethyltoluamide 7.15 % TOPICAL TOWELETTE (EA)


name: diluent for carmustine (ethanol) INTRAVEN VIAL (ML)


name: egg/larch 4.5 gram-1 gram/6.1 gram (scoop) ORAL POWDER (GRAM)


name: hyaluronate sodium 5 mg VAGINAL SUPPOSITORY, VAGINAL


name: nutritional therapy for PKU no.64 34 gram-370 kcal/100 gram ORAL POWDER IN PACKET (EA)


name: nutritional therapy for PKU no.64 38 gram-400 kcal/100 gram ORAL POWDER IN PACKET (EA)


name: urinary bag/catheter 8 Fr-16" MISCELL COMBINATION PACKAGE (EA)


name: OCTINOXATE 0.91 g in 14 g / OCTOCRYLENE 0.42 g in 14 g / TITANIUM DIOXIDE 0.7168 g in 14 g TOPICAL CREAM [AGE 20s SIGNATURE ESSENCE COVER PACT INTENSE COVER 13 IVORY]


name: OCTOCRYLENE 0.42 g in 14 g / OCTINOXATE 0.91 g in 14 g / TITANIUM DIOXIDE 0.7168 g in 14 g TOPICAL CREAM [AGE 20s SIGNATURE ESSENCE COVER PACT LONG STAY 21 LIGHT BEIGE]


name: OCTOCRYLENE 0.56 g in 14 g / TITANIUM DIOXIDE 0.581 g in 14 g / OCTINOXATE 0.98 g in 14 g TOPICAL CREAM [AGE 20s SIGNATURE ESSENCE COVER PACT MOISTURE 21 LIGHT BEIGE]


name: TITANIUM DIOXIDE 42.36 mg in 1 mL / ZINC OXIDE 42.36 mg in 1 mL TOPICAL LOTION [ULTA beauty Broad Spectrum SPF 50 Mineral]


name: TITANIUM DIOXIDE 42.4 mg in 1 mL / ZINC OXIDE 42.4 mg in 1 mL TOPICAL LOTION [Sun Bad Broad Spectrum SPF 50 Mineral]


name: ZINC OXIDE 30.69 mg in 1 mL / TITANIUM DIOXIDE 30.69 mg in 1 mL TOPICAL LOTION [Elizabeth Mott Face Primer Broad Spectrum SPF 30]


name: ZINC OXIDE 30.78 mg in 1 mL / TITANIUM DIOXIDE 30.78 mg in 1 mL TOPICAL LOTION [Goldie Locks Sheer Mineral Sunscreen Broad Spectrum SPF 30]


name: ZINC OXIDE 31.5 mg in 1 mL / TITANIUM DIOXIDE 31.5 mg in 1 mL TOPICAL LOTION [Australian Gold Botanical Mineral Sunscreen Broad Spectrum SPF 30]


name: ZINC OXIDE 41.4 mg in 1 mL / TITANIUM DIOXIDE 41.4 mg in 1 mL TOPICAL LOTION [Australian Gold Botanical Tinted Face Mineral Sunscreen Broad Spectrum SPF 50]


name: PENTOXIFYLLINE 1 g in 1 g NOT APPLICABLE POWDER


name: Lotion, Multi Ingredient Topical application Lotion [GOLD BOND PURE MOISTURE]


name: Cream, Multi Ingredient Topical application Cream [GOLD BOND RADIANCE RENEWAL]


name: Lotion, Multi Ingredient Topical application Lotion [GOLD BOND MEN'S ESSENTIALS INTENSIVE]


name: Cream, Multi Ingredient Topical application Cream [GOLD BOND ROUGH & BUMPY SKIN]


name: Powder, Multi Ingredient Topical application Powder [GOLD BOND MEN'S ESSENTIALS]


name: Spray, Multi Ingredient Topical application Spray [GOLD BOND CLEAR POWDER SPRAY]


name: Spray, Multi Ingredient Topical application Spray [GOLD BOND NO MESS FOOT POWDER]


name: Cream, Multi Ingredient Topical application Cream [GOLD BOND PEDI SMOOTH FOOT]


name: Lotion, Multi Ingredient Topical application Lotion [GOLD BOND AGE RENEW]


name: Lotion, Multi Ingredient Topical application Lotion [GOLD BOND OVERNIGHT]


name: Lotion, Multi Ingredient Topical application Lotion [GOLD BOND RADIANCE RENEWAL]


name: Cream, Multi Ingredient Topical application Cream [GOLD BOND AGE RENEW DARK SPOT MINIMIZING]


name: Cream, Multi Ingredient Topical application Cream [GOLD BOND AGE RENEW NECK & CHEST FIRMING]


name: Lotion, Multi Ingredient Topical application Lotion [GOLD BOND HEALING]


name: Lotion, Multi Ingredient Topical application Lotion [GOLD BOND MEN'S ESSENTIALS EVERYDAY]


name: Lotion, Multi Ingredient Topical application Lotion [GOLD BOND SOFTENING]


name: Lotion, Multi Ingredient Topical application Lotion [GOLD BOND AGE RENEW CREPE CORRECTOR]


name: Cream, Multi Ingredient Topical application Cream [GOLD BOND HEALING]


name: Spray, Multi Ingredient Topical application Spray [GOLD BOND MEN'S ESSENTIALS BODY POWDER]


name: 5-Methyltetrahydrofolate Calcium/Methylcobalamin 15 MG-2 MG Oral Capsule [DENOVO PLUS B-12]


name: Acetaminophen/Dextromethorphan Hydrobromide/Guaifenesin/Phenylephrine Hydrochloride;Acetaminophen/Dextromethorphan Hydrobromide/Phenylephrine Hydrochloride/Triprolidine Hydrochloride 325 MG-10 MG-200 MG-5 MG; 325 MG-10 MG-5 MG-1.25 MG Oral Capsule, Liquid Filled [MUCINEX FAST-MAX/NIGHTSHIFT COMBO]


name: Acetaminophen/Dextromethorphan Hydrobromide/Guaifenesin/Phenylephrine Hydrochloride;Acetaminophen/Dextromethorphan Hydrobromide/Phenylephrine Hydrochloride/Triprolidine Hydrochloride 325 MG-10 MG-200 MG-5 MG; 325 MG-10 MG-5 MG-1.25 MG Oral Capsule, Liquid Filled [MUCINEX SINUS-MAX/NIGHTSHIFT COMBO]


name: L-Methylfolate Glucosamine 400 MCG Oral Capsule [METHYL FOLATE]


name: 5-Methyltetrahydrofolate Calcium/Methylcobalamin 15 MG-2 MG Oral Capsule


name: Avobenzone/Octisalate/Octocrylene 3%-5%-10% Topical application Cream


name: L-Methylfolate Glucosamine 400 MCG Oral Capsule


name: AVOBENZONE 0.03 kg in 1 kg / OCTISALATE 0.05 kg in 1 kg / OCTOCRYLENE 0.095 kg in 1 kg / OCTINOXATE 0.075 kg in 1 kg TOPICAL LOTION [Facet Daily Moisturizer SPF 35]


name: AVOBENZONE 25.89 mg in 1 mL / OCTISALATE 43.15 mg in 1 mL / OCTOCRYLENE 86.3 mg in 1 mL / HOMOSALATE 129.45 mg in 1 mL TOPICAL SPRAY [Pamana Jack Broad Spectrum SPF 75]


name: OCTINOXATE 7 g in 100 mL / ZINC OXIDE 6 g in 100 mL TOPICAL LOTION [Age Defense Mineral Sunscreen Broad Spectrum SPF 25]


name: OCTOCRYLENE 22.99 mg in 1 mL / AVOBENZONE 25.08 mg in 1 mL / OCTISALATE 41.8 mg in 1 mL / HOMOSALATE 83.6 mg in 1 mL TOPICAL SPRAY [Trump Golf Broad Spectrum SPF 30 Sunscreen]


name: TITANIUM DIOXIDE 3.065 mg in 50 mg / OCTOCRYLENE 0.4 mg in 50 mg / OCTINOXATE 2.5 mg in 50 mg TOPICAL CREAM [Belo Sun Expert Tinted Sunscreen]


name: TITANIUM DIOXIDE 30 mg in 1 mL / ZINC OXIDE 100 mg in 1 mL TOPICAL LOTION [CVS HEALTH LIVE BETTER BODY MINERAL SUNSCREEN SPF 30]


name: TITANIUM DIOXIDE 7.75 g in 100 mL / ZINC OXIDE 10 g in 100 mL TOPICAL CREAM [Age Defense Tinted Mineral Sunscreen Broad Spectrum SPF 30]


name: ZINC OXIDE 21 g in 100 g TOPICAL EMULSION [Sunscreen]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 6 g in 100 g TOPICAL CREAM [Olay Whip Plus Hydrating Moisturizer with Sunscreen Broad Spectrum SPF 30]


name: ZINC OXIDE 24.5 g in 100 mL TOPICAL CREAM [SUN and SHINE MINERAL SUNSCREEN]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 90 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL CREAM [e.l.f Whoa Glow Broad Spectrum SPF30 Sunscreen]


name: cardioplegic solution no.33 (warm induction 4:1)


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 20 g in 100 g TOPICAL STICK [Secret Outlast Advanced Invisible Completely Clean]


name: ADENOSINE 0.04 g in 100 mL TOPICAL LIQUID [Tenue 24k gold ampoule]


name: OCTOCRYLENE 2 g in 100 mL / OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL / HOMOSALATE 8 g in 100 mL TOPICAL LOTION [Beach Break 2-in-1 Daily Facial Moisturizer Sunscreen SPF 30]


name: AZAPERONE 1 g in 1 g NOT APPLICABLE POWDER


name: AVOBENZONE 28.89 mg in 1 mL / HOMOSALATE 96.3 mg in 1 mL / OCTISALATE 48.15 mg in 1 mL / OCTOCRYLENE 48.15 mg in 1 mL TOPICAL LOTION [Barunu SPF 50]


name: OCTINOXATE 75 mg in 1 g / AVOBENZONE 30 mg in 1 g / PETROLATUM 423 mg in 1 g TOPICAL STICK [OraLabs SPF 15 Lip Balm]


name: OCTISALATE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g / PETROLATUM 396 mg in 1 g / HOMOSALATE 80 mg in 1 g TOPICAL STICK [ChapIce SPF 30 Lip Balm]


name: ZINC OXIDE 30.9 mg in 1 mL / TITANIUM DIOXIDE 30.9 mg in 1 mL TOPICAL LOTION [NF Skin SPF 30 Broad Spectrum Moisturizer]


name: ALUMINUM SESQUICHLOROHYDRATE 12.8 g in 100 g TOPICAL STICK [Dove]


name: ALUMINUM SESQUICHLOROHYDRATE 9.6 g in 100 g TOPICAL STICK [Dove]


name: DEXPANTHENOL 0.2 g in 100 mL / SALICYLIC ACID 0.2 g in 100 mL / NIACINAMIDE 0.1 g in 100 mL TOPICAL SHAMPOO [CH6 Perfumed Aloforthya Aromatic herb]


name: ZINC OXIDE 18.8 mg in 100 mg TOPICAL CREAM [Cream]


name: HOMOSALATE 15 g in 100 g / OCTISALATE 5 g in 100 g / AVOBENZONE 3 g in 100 g / OCTOCRYLENE 10 g in 100 g TOPICAL SPRAY [Pavin SPF 50 Sunscreen]


name: Respiratory syncytial virus immunisation


name: ALUMINUM CHLOROHYDRATE 12.3 g in 100 mL TOPICAL LIQUID [Jafra Daily Antiperspirant Rollon]


name: OCTINOXATE 3 g in 100 mL / ZINC OXIDE 6.8 g in 100 mL TOPICAL LIQUID [Royal Jelly Radiance Foundation Broad Spectrum SPF 20 Earth]


name: OCTINOXATE 3.681 g in 50 mL / OCTOCRYLENE 1.515 g in 50 mL / AVOBENZONE 1.515 g in 50 mL / OXYBENZONE 1.01 g in 50 mL TOPICAL CREAM [Laura Mercier Pure Canvas Primer Protecting Broad Spectrum SPF 30 Sunscreen]


name: ZINC OXIDE 13.3 g in 100 mL TOPICAL LOTION [Good Molecules Sheer Mineral Sunscreen SPF 30]


name: ZINC OXIDE 0.1995 g in 1 g TOPICAL CREAM [SilkShield All Mineral Sunscreen with TriHex Technology]


name: AVOBENZONE 16.4 mg in 1 mL / OCTISALATE 41.1 mg in 1 mL / OCTOCRYLENE 16.4 mg in 1 mL TOPICAL SPRAY [Hurley Sunscreen Broad Spectrum SPF15]


name: CHLOROXYLENOL 0.10 g in 100 mL TOPICAL SOAP [smart way orange scent dish]


name: AVOBENZONE 2 g in 100 g / OCTISALATE 4.5 g in 100 g / HOMOSALATE 6 g in 100 g / OCTOCRYLENE 6 g in 100 g TOPICAL AEROSOL, SPRAY [BANANA BOAT PROTECTION PLUS VITAMINS SUNSCREEN UVA/UVB BORAD SPECTRUM SPF 30]


name: AVOBENZONE 2.7 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4 g in 100 g / OCTOCRYLENE 5 g in 100 g TOPICAL LOTION [BANANA BOAT PROTECTION PLUS VITAMINS SUNSCREEN UVA/UVB BROAD SPECTRUM SPF 50]


name: AVOBENZONE 2.8 g in 100 g / HOMOSALATE 9.5 g in 100 g / OCTISALATE 4.7 g in 100 g / OCTOCRYLENE 7.5 g in 100 g TOPICAL AEROSOL, SPRAY [HAWAIIAN TROPIC SUNSCREEN CLEAR WEIGHTLESS HYDRATION SPF70]


name: AVOBENZONE 2.8 g in 100 g / OCTISALATE 4.7 g in 100 g / OCTOCRYLENE 8.5 g in 100 g / HOMOSALATE 9.5 g in 100 g TOPICAL LOTION [HAWAIIAN TROPIC SUNSCREEN SHEER TOUCH SPF 70]


name: AVOBENZONE 28 mg in 1 g / OCTOCRYLENE 50 mg in 1 g TOPICAL OINTMENT [CAO Cosmetic Lip Sunscreen SPF 30]


name: Avobenzone 30 mg in 1 mL / Homosalate 150 mg in 1 mL / Octisalate 50 mg in 1 mL / Octocrylene 100 mg in 1 mL TOPICAL GEL [LOreal Paris Revitalift Derm Intensives Invisible UV Fluid Broad Spectrum SPF 50 Sunscreen]


name: HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 6.5 g in 100 g / AVOBENZONE 3 g in 100 g TOPICAL LIQUID [HAWAIIAN TROPIC INVISIBLE SUNSCREEN SHEER TOUCH SPF 50]


name: OCTISALATE 4.5 g in 100 g / AVOBENZONE 2 g in 100 g / HOMOSALATE 5.5 g in 100 g / OCTOCRYLENE 4 g in 100 g TOPICAL LOTION [BANANA BOAT PROTECTION PLUS VITAMINS SUNSCREEN UVA/UVB BORAD SPECTRUM SPF 30]


name: OCTISALATE 4.5 g in 100 g / HOMOSALATE 6 g in 100 g / OCTOCRYLENE 4.5 g in 100 g / AVOBENZONE 2.7 g in 100 g TOPICAL LIQUID [HAWAIIAN TROPIC INVISIBLE SUNSCREEN SHEER TOUCH SPF 30]


name: OCTOCRYLENE 5 g in 100 g / OCTISALATE 4 g in 100 g / AVOBENZONE 2.7 g in 100 g / HOMOSALATE 9 g in 100 g TOPICAL LOTION [BANANA BOAT PROTECTION PLUS VITAMINS FACE SUNSCREEN UVA/UVB BROAD SPECTRUM SPF 50]


name: OCTOCRYLENE 7 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g / AVOBENZONE 2.7 g in 100 g TOPICAL AEROSOL, SPRAY [BANANA BOAT PROTECTION PLUS VITAMINS SUNSCREEN UVA/UVB BORAD SPECTRUM SPF 50]


name: TITANIUM DIOXIDE 9 g in 100 g / ZINC OXIDE 6.3 g in 100 g TOPICAL CREAM [toty Ilumina CC Cream 1C]


name: ZINC OXIDE 220 mg in 1 mL TOPICAL CREAM [Suzanne Organics Tinted Mineral Sunscreen Broad Spectrum SPF 25 - Bronze]


name: ZINC OXIDE 220 mg in 1 mL TOPICAL CREAM [Suzanne Organics Tinted Mineral Sunscreen Broad Spectrum SPF 25 - Sand]


name: LIDOCAINE HYDROCHLORIDE 10 mg in 1 mL TOPICAL SOLUTION [INTIMALE LIDOCAINE DELAY]


name: LIDOCAINE HYDROCHLORIDE 10 mg in 1 mL TOPICAL SOLUTION [POWERECT Lidocaine Male Delay]


name: LIDOCAINE HYDROCHLORIDE 10 mg in 1 mL TOPICAL SOLUTION [SKINS DELAY Climax Control Lidocaine]


name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [INTIMALE Benzocaine Delay Gel]


name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [POWERECT Benzocaine Male Delay Gel]


name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [SKINS DELAY Climax Control Benzocaine Gel]


name: TITANIUM DIOXIDE 65 mg in 1 mL / ZINC OXIDE 187 mg in 1 mL TOPICAL LOTION [Aveeno Protect Plus Soothe Mineral Sunscreen Broad Spectrum SPF 30]


name: TITANIUM DIOXIDE 65 mg in 1 mL / ZINC OXIDE 187 mg in 1 mL TOPICAL LOTION [Neutrogena Mineral Beach Defense Active Performance Sunscreen Broad Spectrum SPF 30]


name: methyltetrahydrofolate calcium/mecobalamin 25,000 mcg DFE-2,000 mcg ORAL CAPSULE


name: nutritional therapy for PKU no.64 38 gram-400 kcal/100 gram ORAL POWDER (GRAM)


name: zinc oxide 16 %-40 % TOPICAL OINTMENT (GRAM)


name: diluent for triamcinolone acetonide ER (carboxymethyl) INTRAARTIC VIAL (ML)


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 80 mg in 1 g TOPICAL SPRAY [Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / Homosalate 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL Lotion [Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / Homosalate 120 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL Lotion [sheer]


name: OCTINOXATE 0.91 g in 14 g / OCTOCRYLENE 0.42 g in 14 g / TITANIUM DIOXIDE 0.7168 g in 14 g TOPICAL CREAM [AGE 20s SIGNATURE ESSENCE COVER PACT INTENSE COVER 31 MEDIUM TAN]


name: TITANIUM DIOXIDE 7.75 g in 100 mL / ZINC OXIDE 10 g in 100 mL TOPICAL CREAM [Desert Sun Protection Broad Spectrum SPF30]


name: OCTINOXATE 7 g in 100 mL / ZINC OXIDE 6 g in 100 mL TOPICAL LOTION [Desert Sun Protection Broad Spectrum SPF 25]


name: diluent for triamcinolone ER (carboxymethyl)


name: Dove Baby Sensitive Moisture, topical lotion


name: Baby Dove Body Wash Fragrance Free, topical soap


name: Azo Test Strips Urinary Tract Infection Test


name: Cara Ice Bag Cold Therapy 6 Inch Diameter


name: Cara Ice Bag Cold Therapy 9 Inch Diameter


name: Carefree Acti-Fresh Thin Unscented Liners


name: Carefree Acti-Fresh Unscented Regular Liners


name: Dove Style + Care Flexible Hold Hair Spray


name: Garnier Fructis Anti-Humidity Smoothing Milk


name: Garnier Fructis Color Shield Conditioner


name: Garnier Fructis Moroccan Sleek Oil Treatment


name: Garnier Fructis Sleek And Shine Conditioner


name: Garnier Fructis Sleek Shine Anti-Frizz Serum


name: Garnier Fructis Style Anti-Humidity Hairspray


name: Garnier Fructis Style Curl Sculpt Cream Gel


name: Garnier Fructis Style Curl Shape Spray Gel


name: Garnier Fructis Style Full Control Hairspray


name: Garnier Fructis Style Pure Clean Styling Gel


name: Gillette Clinical Ultimate Fresh Deodorant


name: Head And Shoulders Clinical Strength Shampoo


name: Herbal Essences Argan Oil Repair Conditioner


name: Herbal Essences Argan Oil Repair Shampoo


name: Herbal Essences Coconut Milk Conditioner


name: Herbal Essences Coconut Milk Hydrate Shampoo


name: Herbal Essences White Grapefruit Conditioner


name: Herbal Essences White Grapefruit Shampoo


name: Hypocyn Antimicrobial Dermal Spray Solution


name: Loreal Paris Elvive Repairing Conditioner


name: Loreal Paris Ever Pure Moisture Conditioner


name: Nature's Truth Sweet Almond Skin Care Oil


name: Nexxus Therappe Ultimate Moisture Shampoo


name: Old Spice Antiperspirant Deodorant Swagger


name: Old Spice Classic Scent Men's After Shave


name: Old Spice Timber With Sandalwood Deodorant


name: Old Spice Volcano With Charcoal Deodorant


name: Pantene Classic Clean Shampoo + Conditioner


name: Pantene Daily Moisture Shampoo + Conditioner


name: Pantene Smooth And Sleek Shampoo Conditioner


name: Pantene Volume And Body Shampoo Conditioner


name: Pantene Volume Texture Building Hairspray


name: Playtex Sport Unscented Tampons Regular 18


name: Secret Antiperspirant Clear Gel Boho Berry


name: Secret Antiperspirant Clear Gel, Lavender


name: Secret Clinical Strength Soft Solid Deodorant


name: Secret Out Last Clear Gel Antiperspirant


name: Secret Out Last Sweat And Odor Antiperspirant


name: Silinoin Medical-Grade Silicone Gel Sheeting


name: Stayfree Maxi Super Long With Wings Pads


name: Stayfree Ultra Thin Overnight With Wings Pads


name: Strength Tape Back And Neck Precut Strips


name: Strength Tape Calf And Quad Precut Strips


name: Strength Tape Foot And Ankle Precut Strips


name: Sure Comfort Insulin Pen Needles 32g 4mm


name: Tresemme Clean And Replenish Conditioner


name: Tresemme Flawless Curls Moisturizing Mousse


name: Yardley London Bath Bar Aloe Vera And Avocado


name: Whey Protein Isolate Oral Powder for Suspension [NEW ZEALAND WHEY PROTEIN ISOLATE]


name: magnesium carbonate, magnesium glycinate


name: OCTINOXATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL / TITANIUM DIOXIDE 52 mg in 1 mL / ZINC OXIDE 32 mg in 1 mL TOPICAL CREAM [MOISTURE SURGE CC BROAD SPECTRUM SPF 30 HYDRATING COLOUR CORRECTOR]


name: GLYCERIN 1.9 g in 100 mL / BIOTIN 0.02 g in 100 mL TOPICAL LIQUID [Dr. Zonskin Nunssup Jara]


name: FEED SET,ENTERAL PUMP ENFIT CARDINAL #1000KCP


name: CATHETER,FOLEY SILICONE COATED 2-WAY 14FR 5ML RUSCH #180705140


name: DRESSING,PRIMATRIX 4CM X 4CM,FENESTRATED


name: DRESSING,OPTIFOAM GENTLE EX SACRUM 9IN X 9IN #MSCEX99EP


name: VAD DRIVELINE MAINTENANCE KIT CENTURION #DT18675


name: TUBE FEEDING SET,EXTENSION ENFIT#0144-12


name: DRESSING,TEGADERM,FOAM 2-3/4IN X 3IN 3M#90614


name: STOMA CAPTURE CARTRIDGE STOMAGIENICS #12018


name: Castor Oil, Hydrogenated, Ethoxylated Bulk liquid


name: Infant and Toddler Multivitamin Drops (Cherry)


name: Infant and Toddler Multivitamin with Iron Drops (Cherry)


name: Infant and Toddler Vitamin A, C, and D Multivitamin Drops (Cherry)


name: Contour Next GEN Blood Glucose Monitor System


name: Luminopia Digital Therapeutic Software for Pediatric Amblyopia


name: UniSpend Anhydrous Sweetened Base for Compounding


name: Uresta Bladder Support for Women Starter Kit


name: OCTINOXATE 50 mg in 1 mL / ZINC OXIDE 29.4 mg in 1 mL TOPICAL EMULSION [LBEL FOREVER HYDRA BASE HIDRATANTE DE LARGA DURACION FPS 15 HYDRATING LONGWEAR FOUNDATION SPF 15 ALMENDRA 230-N]


name: TITANIUM DIOXIDE 10.03 g in 100 g / OCTINOXATE 7 g in 100 g / OCTISALATE 4.5 g in 100 g / ZINC OXIDE 4.9 g in 100 g TOPICAL CREAM [LAUNDRYOU CLEAR DEFENSE CUSHION GLOW 21 UYUNI BEIGE]


name: TITANIUM DIOXIDE 10.03 g in 100 g / ZINC OXIDE 4.9 g in 100 g TOPICAL CREAM [LAUNDRYOU MOISTURE SUN CUSHION CLEAR]